A study of the long-term safety and mechanism of action of alemtuzumab, an experimental drug used in Multiple Sclerosis

Study code
CBR74

Lead researcher
Dr. Anu Kemppinen

Study type
Participant re-contact

Institution or company
University of Cambridge

Researcher type
Academic

Speciality area
Neurological Disorders

Recruitment Site
Cambridge

Summary

This research study is looking at genes that control the immune system, which have been identified as being important in the disease called multiple sclerosis. The main purpose of this study is to see how these genes influence the effectiveness of an experimental drug (alemtuzumab) in the treatment of Multiple Sclerosis